'Big Win' for Anti-Obesity Medication in Heart Failure

(MedPage Today) -- In this video, Harlan Krumholz, MD, SM, of the Yale School of Medicine and Yale New Haven Hospital in Connecticut, discusses a randomized trial that showed semaglutide (Wegovy) led to improvements in symptoms and weight for heart...
Source: MedPage Today Nephrology - Category: Urology & Nephrology Source Type: news